These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15623668)

  • 1. Immunopathology of multiple sclerosis.
    Fox EJ
    Neurology; 2004 Dec; 63(12 Suppl 6):S3-7. PubMed ID: 15623668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects of multiple sclerosis.
    Boppana S; Huang H; Ito K; Dhib-Jalbut S
    Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remyelination protects axons from demyelination-associated axon degeneration.
    Irvine KA; Blakemore WF
    Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Properties of Cytokines in Multiple Sclerosis: Pros and Cons.
    Wang K; Song F; Fernandez-Escobar A; Luo G; Wang JH; Sun Y
    Am J Med Sci; 2018 Dec; 356(6):552-560. PubMed ID: 30447707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological aspects of axon injury in multiple sclerosis.
    Howe CL
    Curr Top Microbiol Immunol; 2008; 318():93-131. PubMed ID: 18219816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction.
    Grigoriadis N; Grigoriadis S; Polyzoidou E; Milonas I; Karussis D
    Clin Neurol Neurosurg; 2006 Mar; 108(3):241-4. PubMed ID: 16388896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.
    Rieckmann P; Mäurer M
    Curr Opin Neurol; 2002 Jun; 15(3):361-70. PubMed ID: 12045738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
    Onuki M; Ayers MM; Bernard CC; Orian JM
    Microsc Res Tech; 2001 Mar; 52(6):731-9. PubMed ID: 11276125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K; Brück W; Kuhlmann T
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.
    Kuhlmann T; Lingfeld G; Bitsch A; Schuchardt J; Brück W
    Brain; 2002 Oct; 125(Pt 10):2202-12. PubMed ID: 12244078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.